Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for military-related posttraumatic stress disorder.  For more information, please visit www.thehonorstudy.com or www.clinicaltrials.gov (NCT03062540).

SEC Filings
: All SEC Filings

All SEC Filings

Filter Filings:
Date Form Description Docs XBRL Pages
12/02/16 8-K Current report filing
Related Documents
4
11/30/16 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Related Documents
10
11/28/16 4 Statement of changes in beneficial ownership of securities 2
11/22/16 4 Statement of changes in beneficial ownership of securities 2
11/10/16 8-K Current report filing
Related Documents
7
11/10/16 10-Q Quarterly report pursuant to Section 13 or 15(d)
Related Documents
34
11/10/16 8-K Current report filing
Related Documents
7
11/04/16 SC 13G Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions 6
11/04/16 8-K Current report filing
Related Documents
4
11/01/16 8-K Current report filing
Related Documents
33